The ESMO Novel Cancer Therapies 2027
The ESMO Novel Cancer Therapies 2027, organized by the European Society for Medical Oncology (ESMO), will take place on March 8–10, 2027, in Lugano, Switzerland.
This new ESMO meeting is designed for multidisciplinary oncology professionals and will focus on how approved novel cancer therapies can be translated into everyday clinical practice, with particular attention to treatment selection, practical implementation, toxicity prevention and management, and optimizing patient outcomes.
The programme will combine expert presentations, multidisciplinary discussions, real-world clinical cases, and peer-to-peer learning. Day 1 will feature a major focus on antibody-drug conjugates (ADCs), including their clinical use, supportive care considerations, management of ADC-related toxicities, and practical issues around combinations and treatment sequencing.